Scarica l'app Stockscreener
8.62
1.53%
0.13
Precedente Chiudi:
$8.49
Aprire:
$8.62
Volume 24 ore:
4.74M
Relative Volume:
0.68
Capitalizzazione di mercato:
$1.60B
Reddito:
$2.59B
Utile/perdita netta:
$-981.73M
Rapporto P/E:
-1.4939
EPS:
-5.77
Flusso di cassa netto:
$206.95M
1 W Prestazione:
-5.79%
1M Prestazione:
-39.85%
6M Prestazione:
+6.55%
1 anno Prestazione:
-41.91%
Intervallo 1D:
$8.47
$8.705
Intervallo di 1 settimana:
$8.47
$9.24
Portata 52W:
$6.76
$15.68
Teladoc Health Inc Stock (TDOC) Company Profile
Nome
Teladoc Health Inc
Settore
Industria
Telefono
(203) 635-2002
Indirizzo
2 MANHATTANVILLE ROAD, PURCHASE, NY
Confronta TDOC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
8.62 | 1.60B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
234.06 | 38.00B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
74.16 | 12.83B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
63.38 | 11.89B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
97.41 | 8.44B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
47.17 | 8.12B | 640.44M | -743.28M | -206.93M | -11.29 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-15 | Iniziato | Goldman | Buy |
| 2024-09-17 | Reiterato | Jefferies | Hold |
| 2024-02-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-17 | Downgrade | DA Davidson | Buy → Neutral |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-04-12 | Iniziato | Stephens | Equal-Weight |
| 2023-02-23 | Aggiornamento | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Aggiornamento | Guggenheim | Sell → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-17 | Downgrade | Guggenheim | Neutral → Sell |
| 2022-08-12 | Iniziato | DA Davidson | Buy |
| 2022-08-02 | Downgrade | Berenberg | Buy → Hold |
| 2022-08-02 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-07-28 | Downgrade | Goldman | Buy → Neutral |
| 2022-07-28 | Downgrade | Needham | Buy → Hold |
| 2022-07-06 | Reiterato | BofA Securities | Neutral |
| 2022-05-05 | Downgrade | Argus | Buy → Hold |
| 2022-04-28 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-28 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-04-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-03 | Aggiornamento | Argus | Hold → Buy |
| 2022-02-23 | Reiterato | BofA Securities | Neutral |
| 2022-02-23 | Reiterato | Craig Hallum | Hold |
| 2022-02-23 | Reiterato | Evercore ISI | In-line |
| 2022-02-23 | Reiterato | Goldman | Buy |
| 2022-02-23 | Reiterato | JP Morgan | Overweight |
| 2022-02-23 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Reiterato | Needham | Buy |
| 2022-02-23 | Reiterato | Oppenheimer | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2022-02-08 | Reiterato | Piper Sandler | Overweight |
| 2021-12-02 | Ripresa | Jefferies | Hold |
| 2021-11-22 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-10-28 | Reiterato | Barclays | Equal Weight |
| 2021-10-28 | Reiterato | BofA Securities | Neutral |
| 2021-10-28 | Reiterato | Canaccord Genuity | Buy |
| 2021-10-28 | Reiterato | Citigroup | Buy |
| 2021-10-28 | Reiterato | Craig Hallum | Hold |
| 2021-10-28 | Reiterato | Needham | Buy |
| 2021-10-28 | Reiterato | Oppenheimer | Outperform |
| 2021-10-28 | Reiterato | Piper Sandler | Overweight |
| 2021-10-28 | Reiterato | UBS | Neutral |
| 2021-10-19 | Iniziato | Wells Fargo | Overweight |
| 2021-08-02 | Downgrade | Argus | Buy → Hold |
| 2021-07-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-15 | Iniziato | Needham | Buy |
| 2021-01-07 | Iniziato | BTIG Research | Buy |
| 2020-12-22 | Iniziato | Evercore ISI | In-line |
| 2020-12-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Iniziato | Goldman | Neutral |
| 2020-11-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Iniziato | DA Davidson | Buy |
| 2020-09-02 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-08-17 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Iniziato | Citigroup | Buy |
| 2020-07-13 | Iniziato | Argus | Buy |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-04-30 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Iniziato | SVB Leerink | Outperform |
| 2020-03-31 | Downgrade | Berenberg | Buy → Hold |
| 2020-03-25 | Downgrade | Craig Hallum | Buy → Hold |
| 2020-03-16 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Iniziato | UBS | Neutral |
| 2020-01-09 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Teladoc Health Inc Borsa (TDOC) Ultime notizie
Teladoc Expands Specialty Care Access With Carrum Health Partnership - MSN
Carrum Health Selected by Teladoc Health as Centers of Excellence Partner - Quantisnow
Teladoc's Game-Changing Partnership Solves Major Healthcare Integration Challenge for 93M Members - StockTitan
Virtual Health Service Market Projected To Witness Substantial Growth 2025-2032:Teladoc Health, Amwell, Doctor - EIN News
Teladoc Doubles Down on Connected Care With New Partnerships - MSN
Cylinder joins Teladoc Health’s Connected Care Program to expand access to virtual digestive care - TradingView
Teladoc (TDOC) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Teladoc partners with virtual fertility, digestive care companies - Modern Healthcare
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc.TDOC - PR Newswire
Teladoc Health Expands Connected Care Partnerships - GlobeNewswire
Teladoc Health Expands Connected Care Partnerships to Enhance Virtual Health Services Across Multiple Care Categories - Nasdaq
Teladoc Health Adds 4 Game-Changing Partners to Transform Virtual Healthcare Delivery - StockTitan
Proficio Capital Partners LLC Acquires New Stake in Teladoc Health, Inc. (NYSE:TDOC) - Defense World
Teladoc Boosts Weight Care Access With LillyDirect, Aids Growth - Yahoo Finance
Digital Therapeutics Market is expected to reach US$ 27.3 - openPR
Teladoc Health, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationTDOC - ACCESS Newswire
Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Principal Financial Group Inc. - Defense World
Teladoc Health (NYSE:TDOC) Shares Gap Down – Here’s What Happened - Defense World
Teladoc short seller attack on therapy unit highlights rise of AI - BenefitsPro
Eli Lilly Direct-To-Consumer Push Shouldn't Worry Distributors: JPMorgan - Benzinga
Teladoc Health, Inc. to Host Earnings Call - ACCESS Newswire
Teladoc Health executive sells shares worth $32,733 - Investing.com
Teladoc stock jumps on GLP-1 deal with Eli Lilly - Yahoo Finance
Truist maintains Teladoc stock Hold rating, $10 target - Investing.com
LifeMD and Teladoc Health partner with LillyDirect pharmacy provider Gifthealth for Zepbound - MSN
Teladoc partners with Eli Lilly, Burlington stock rises: Market Minute - Yahoo Finance
Truist Securities Reiterates Hold Rating on Teladoc (TDOC) - StreetInsider.com
Two telehealth firms turn to branded Zepbound as restrictions loom on copies - Reuters
Teladoc, LifeMD partner with Eli Lilly on GLP-1s - Modern Healthcare
Teladoc Health Partners With Eli Liily's LillyDirect to Expand Access to Zepbound For Weight Loss - Benzinga
Teladoc Health Provides Self-Pay Option for Eli Lilly's Obesity Drug -March 06, 2025 at 09:31 am EST - Marketscreener.com
Teladoc shares rise on partnership with LillyDirect on weight care program - Investing.com
Teladoc Health Adds GLP-1 Self-Pay Option To Comprehensive Weight Care -March 06, 2025 at 09:09 am EST - Marketscreener.com
Teladoc announces pharmacy integration agreement with Gifthealth - TipRanks
Teladoc shares rise on partnership with LillyDirect on weight care program By Investing.com - Investing.com Canada
Telehealth firms Teladoc, LifeMD tie up with Eli Lilly's pharmacy partner to offer Zepbound - TradingView
Teladoc Health Adds GLP-1 Self-Pay Option to Comprehensive Weight Care - GlobeNewswire
TDOCTeladoc Health Inc Latest Stock News & Market Updates - StockTitan
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - GlobeNewswire
The Future of Telemedicine: $488.89 Billion Market by 2033, - openPR
Teladoc's Latest Acquisition Comes With Nearly 1M Share Compensation Package - StockTitan
Teladoc Health Enhances Prism Platform for Better Virtual Care - MSN
Avoid these Two Stocks - Baystreet.ca
Best Telemedicine Services for 2025 - CNET
Teladoc Health’s president sells $28,122 in stock By Investing.com - Investing.com South Africa
Teladoc health chief legal officer Adam Vandervoort sells $38,106 in stock - Investing.com Australia
Teladoc Health’s president sells $28,122 in stock - Investing.com India
Teladoc Health Inc Azioni (TDOC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
4.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):